Tracking Human Cardiac Subtype Specification Using Molecular Beacons

使用分子信标跟踪人类心脏亚型规范

基本信息

  • 批准号:
    8664914
  • 负责人:
  • 金额:
    $ 18.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human cardiac tissues have limited regenerative capacity. Damage in cardiac tissues from ischemia or other pathological conditions can result in heart failure, the leading cause of death in the United States. In addition, cell loss or dysfunctin in pacemaker tissues due to congenital heart defects, aging, and acquired diseases that damage the conduction system can cause severe arrhythmias. Human pluripotent stem cells hold great promise for cardiac cell therapy. These cells can be differentiated into nodal and working (atrial and ventricular) cardiac subtypes, which are suitable for different applications: enriched working-type cells without the contamination of nodal-type cells for repairing injured ventricular myocardium, and enriched nodal-type cells for developing a biological pacemaker. However, none of the existing methods can generate homogeneous cells for a specific subtype, and methods for the isolation and enrichment of each subtype have not been well developed. Research on cardiac subtype specification has been challenging due to the lack of an analysis tool that can be used in a throughput platform to distinguish and enrich cardiac subtypes. This R21 proposal aims to track, enrich and characterize cardiac subtypes using a novel nanotechnology based tool without genetically modifying the cells. This technology will allow us to generate highly homogeneous nodal- or working-type cell populations and therefore facilitate future applications of human pluripotent stem cells in cardiac cell therapy. It can also help accelerate studies to understand the regulation of cardiac subtype specification from human pluripotent stem cells.
描述(由申请人提供):人体心脏组织的再生能力有限。心肌缺血或其他病理状态引起的心脏组织损伤可导致心力衰竭,心力衰竭是美国的主要死因。此外,由于先天性心脏缺陷、衰老和损害传导系统获得性疾病引起的起搏器组织中的细胞损失或功能障碍可引起严重心律失常。人类多能干细胞在心脏细胞治疗中具有巨大的前景。这些细胞可以分化为结型和工作型(心房和心室)心脏亚型,它们适用于不同的应用:富集的工作型细胞,而不污染心肌型细胞,用于修复受损的心室肌,富集的心肌型细胞用于开发生物起搏器。然而,现有的方法都不能产生特定亚型的同质细胞,并且用于分离和富集每种亚型的方法还没有得到很好的开发。由于缺乏可用于通量平台以区分和丰富心脏亚型的分析工具,心脏亚型规范的研究一直具有挑战性。这项R21提案旨在使用一种基于纳米技术的新工具来跟踪、富集和表征心脏亚型,而无需对细胞进行遗传修饰。这项技术将使我们能够产生高度同质的结节型或工作型细胞群,从而促进人类多能干细胞在心脏细胞治疗中的未来应用。它还可以帮助加速研究,以了解人类多能干细胞对心脏亚型特化的调节。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microscale generation of cardiospheres promotes robust enrichment of cardiomyocytes derived from human pluripotent stem cells.
  • DOI:
    10.1016/j.stemcr.2014.06.002
  • 发表时间:
    2014-08-12
  • 期刊:
  • 影响因子:
    5.9
  • 作者:
    Nguyen, Doan C.;Hookway, Tracy A.;Wu, Qingling;Jha, Rajneesh;Preininger, Marcela K.;Chen, Xuemin;Easley, Charles A.;Spearman, Paul;Deshpande, Shriprasad R.;Maher, Kevin;Wagner, Mary B.;McDevitt, Todd C.;Xu, Chunhui
  • 通讯作者:
    Xu, Chunhui
Cell alignment induced by anisotropic electrospun fibrous scaffolds alone has limited effect on cardiomyocyte maturation.
  • DOI:
    10.1016/j.scr.2016.04.014
  • 发表时间:
    2016-05
  • 期刊:
  • 影响因子:
    1.2
  • 作者:
    Han J;Wu Q;Xia Y;Wagner MB;Xu C
  • 通讯作者:
    Xu C
Molecular beacon-based detection and isolation of working-type cardiomyocytes derived from human pluripotent stem cells.
  • DOI:
    10.1016/j.biomaterials.2015.01.043
  • 发表时间:
    2015-05
  • 期刊:
  • 影响因子:
    14
  • 作者:
    Jha, Rajneesh;Wile, Brian;Wu, Qingling;Morris, Aaron H.;Maher, Kevin O.;Wagner, Mary B.;Bao, Gang;Xu, Chunhui
  • 通讯作者:
    Xu, Chunhui
Efficient differentiation of cardiomyocytes from human pluripotent stem cells with growth factors.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Chunhui Xu其他文献

Chunhui Xu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Chunhui Xu', 18)}}的其他基金

Alcohol-induced cardiac injury and repair in human induced pluripotent stem cell model
人诱导多能干细胞模型中酒精引起的心脏损伤和修复
  • 批准号:
    10599235
  • 财政年份:
    2021
  • 资助金额:
    $ 18.79万
  • 项目类别:
Alcohol-induced cardiac injury and repair in human induced pluripotent stem cell model
人诱导多能干细胞模型中酒精引起的心脏损伤和修复
  • 批准号:
    10394370
  • 财政年份:
    2021
  • 资助金额:
    $ 18.79万
  • 项目类别:
Alcohol-induced cardiac injury and repair in human induced pluripotent stem cell model
人诱导多能干细胞模型中酒精引起的心脏损伤和修复
  • 批准号:
    10209255
  • 财政年份:
    2021
  • 资助金额:
    $ 18.79万
  • 项目类别:
Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
人多能干细胞来源的心肌细胞的成熟
  • 批准号:
    9447662
  • 财政年份:
    2018
  • 资助金额:
    $ 18.79万
  • 项目类别:
Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes
人多能干细胞来源的心肌细胞的成熟
  • 批准号:
    10091506
  • 财政年份:
    2018
  • 资助金额:
    $ 18.79万
  • 项目类别:
Safety Assessment of Pluripotent Stem Cell Therapy Using Nanotechnology
使用纳米技术的多能干细胞疗法的安全性评估
  • 批准号:
    8752641
  • 财政年份:
    2014
  • 资助金额:
    $ 18.79万
  • 项目类别:
Safety Assessment of Pluripotent Stem Cell Therapy Using Nanotechnology
使用纳米技术的多能干细胞疗法的安全性评估
  • 批准号:
    8902262
  • 财政年份:
    2014
  • 资助金额:
    $ 18.79万
  • 项目类别:
Tracking Human Cardiac Subtype Specification Using Molecular Beacons
使用分子信标跟踪人类心脏亚型规范
  • 批准号:
    8491581
  • 财政年份:
    2013
  • 资助金额:
    $ 18.79万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 18.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了